Table 2 ADA levels in sera from patients treated with IFX and untreated healthy controls
From: B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera
Patient ID | Age | Gender | ADA (µg/ml) | Control ID | Age | Gender | ADA (µg/ml) |
|---|---|---|---|---|---|---|---|
438 | 29 | M | 54.1 | P* | 48 | F | <1.25 |
452 | 30 | F | 63.9 | F10 | 20 | M | <1.25 |
485 | 64 | F | 74.1 | F22 | 25 | F | <1.25 |
522 | 42 | F | 45.9 | F28 | 22 | M | <1.25 |
587 | 41 | F | 78.4 | F31 | 45 | M | <1.25 |
609 | 30 | M | >80 | F32 | 59 | F | <1.25 |
623 | 57 | F | 53.9 | F33 | 25 | F | <1.25 |
626 | 57 | F | 44.1 | F38 | 53 | F | <1.25 |
638 | 32 | M | 39.3 | F41 | 19 | M | <1.25 |
639 | 33 | M | 47.4 | F42 | 32 | M | <1.25 |
648 | 4 | F | 34.2 | F43 | 31 | F | <1.25 |
652 | 31 | M | 29.7 | F44 | 44 | F | <1.25 |
660 | 26 | M | 14.4 | F45 | 36 | F | <1.25 |
681 | – | – | 24.1 | F46 | 35 | F | <1.25 |
694 | 13 | F | 45.6 | F47 | 33 | F | <1.25 |
695 | 37 | M | 59.9 | ||||
719 | 16 | F | 69.7 | ||||
721 | – | – | >80 | ||||
722 | 42 | M | 44.8 | ||||
724 | 80 | F | 32.6 |